Write your message
Iranian Journal of Breast Diseases                   Back to the articles list | Back to browse issues page

XML Persian Abstract Print


Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. , drmrsh@gmail.com
Abstract:   (43 Views)

Should “Cancer Patient” Be Replaced by “Cancer Survivor”? A Psychological and Cross-Cultural Perspective from Iran
Recent international efforts have increasingly encouraged replacing the term “cancer patient” with “cancer survivor” in clinical practice, research, and public discourse. This movement aims to reduce stigma, foster hope, promote empowerment, and recognize the long-term physical, psychological, and social challenges experienced by individuals diagnosed with cancer. From a psychological perspective, initiatives that improve patients’ well-being and reduce stigma deserve careful consideration and support. Nevertheless, whether this terminology should be universally adopted across languages and cultural settings remains an open question (1).
Reducing disease-related stigma has become an important objective across many areas of medicine(2). In psychiatry, person-first language has progressively replaced disease-defining labels; for example, schizophrenic patients have largely been replaced by patients with schizophrenia, while terms such as substance abuse and addiction have increasingly been replaced by substance use disorder(3-5). These changes primarily aim to reduce labeling and emphasize the individual rather than the illness. However, replacing the word patient itself with an alternative term such as survivor represents a conceptually different type of linguistic change and may have distinct psychological, cultural, and practical implications.

The term cancer survivor offers several potential advantages. It may convey hope, resilience, and recovery, reduce perceived stigma, strengthen personal identity, and facilitate peer support and survivorship advocacy. These benefits have contributed to its widespread acceptance in many English-speaking countries, where survivorship has evolved into a distinct area of oncology care(1).
Nevertheless, the applicability of this terminology may differ across cultures and languages(6). In countries such as Iran, using the term survivor throughout the disease trajectory—from the time of diagnosis to advanced or metastatic disease—may unintentionally create ambiguity regarding prognosis, encourage unrealistic expectations, or reduce the perceived seriousness of the illness among some patients and families. Importantly, these concerns remain hypothetical because, to our knowledge, no rigorous empirical study has examined the perspectives of Iranian patients, family caregivers, healthcare professionals, or policymakers regarding alternative cancer-related terminology.
Translation presents an additional challenge. In Persian, there is no direct equivalent that fully captures the meaning of the English term "cancer survivor". The literal translation, بازمانده سرطان, is vague and may be misunderstood. In contrast, alternatives such as فرد نجات‌یافته از سرطان appear more appropriate only after successful completion of treatment and in situations where the likelihood of recurrence is relatively low. These linguistic differences illustrate that terminology cannot always be transferred directly across cultures without altering its psychological and social meaning.
Furthermore, the terminology used in public communication need not be necessarily identical to that used in scientific literature. This distinction is particularly relevant in multilingual societies, where research is conducted primarily in English while communication with patients occurs in Persian or other local languages and dialects. Consequently, terminology appropriate in international scientific publications may not have the same psychological effects when translated into routine clinical communication (7).
Another consideration is the potential influence of terminology on healthcare policy and administrative systems. Before replacing established terms, policymakers should evaluate whether such changes could unintentionally affect insurance regulations, financial support programs, eligibility criteria, or legal documents in which the designation patient may have practical significance. Although empirical evidence on such consequences is limited, careful policy evaluation should accompany any large-scale change in terminology.
From a cultural perspective, it may also be argued that the word “cancer” itself evokes stronger fear and stigma than the word "patient". In Persian literature and everyday language, cancer has historically been associated with suffering, hopelessness, and catastrophe. Therefore, efforts to reduce stigma may achieve greater benefit by addressing public attitudes toward cancer itself rather than focusing exclusively on replacing the word patient.
In summary, current evidence does not support the universal adoption of the term cancer survivor across all linguistic and cultural settings. While the terminology may be appropriate in English-language scientific publications and in healthcare systems where survivorship has become an established concept, its routine application in clinical practice and public communication should await evidence regarding its psychological, cultural, and policy implications. Future research should explore the attitudes of patients, family caregivers, healthcare professionals, and policymakers toward existing and alternative terminology and evaluate whether linguistic changes genuinely improve psychological well-being, reduce stigma, and enhance patient-centered care across different cultural contexts.
Given the absence of empirical evidence from Iran, the Iranian Journal of Breast Diseases could make a valuable contribution by considering a dedicated call for papers on cancer-related terminology, stigma, and patient-centered communication. Such an initiative could encourage multidisciplinary research that explores the perspectives of patients, family caregivers, healthcare professionals, policymakers, linguists, psychologists, and sociologists on the appropriateness, acceptability, and potential consequences of existing and alternative terminology in Persian. Evidence generated through such work could provide a stronger scientific foundation for future recommendations and terminology policies in oncology care.

Competing interests
The author has no conflicts of interest to report.
 

     
Study Type: commentary | Subject: Diagnosis, treatment, rehabilitation
Received: 2026/10/28 | Accepted: 2026/11/19

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Iranian Journal of Breast Diseases

Designed & Developed by: Yektaweb